Holen Sie sich die Stockscreener-App
2.09
1.42%
-0.03
Handel nachbörslich:
2.14
0.05
+2.39%
Schlusskurs vom Vortag:
$2.12
Offen:
$2.12
24-Stunden-Volumen:
1.92M
Relative Volume:
1.41
Marktkapitalisierung:
$155.37M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-12.18
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
+0.48%
1M Leistung:
-32.80%
6M Leistung:
-15.04%
1J Leistung:
-30.33%
1-Tages-Spanne:
$1.955
$2.1692
1-Wochen-Bereich:
$1.955
$2.54
52-Wochen-Spanne:
$1.60
$5.3881
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
2.09 | 157.60M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Eingeleitet | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Perspective Therapeutics Inc Stock Analysis and ForecastMonthly Performance Summary & Bull Bear Market Updates - earlytimes.in
UBS Maintains Perspective Therapeutics (CATX) Buy Recommendation - Nasdaq
Perspective Therapeutics (CATX): UBS Maintains Rating but Lowers Price Target | CATX Stock News - GuruFocus
UBS lowers Perspective Therapeutics stock price target on competition concerns - Investing.com Nigeria
How Perspective Therapeutics Inc. stock reacts to stronger dollarBull Run & Stock Timing and Entry Methods - newser.com
Will Perspective Therapeutics Inc. stock outperform global peersQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Why Perspective Therapeutics Inc. stock could rally stronglyEarnings Summary Report & Risk Managed Investment Signals - newser.com
Is Perspective Therapeutics Inc. stock attractive for hedge fundsJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Is Perspective Therapeutics Inc. stock attractive post correction2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
What machine learning models say about Perspective Therapeutics Inc.Weekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
How geopolitical risks impact Perspective Therapeutics Inc. (AAJ0) stockJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Perspective Therapeutics to Participate in Upcoming December Conferences - The Manila Times
Perspective Therapeutics, Inc. Announces Participation in Upcoming Healthcare Conferences for Investor Engagement - Quiver Quantitative
Perspective (CATX) to meet investors at Piper Sandler and Evercore healthcare events - Stock Titan
Can Perspective Therapeutics Inc. stock attract ESG investmentsWall Street Watch & Verified Momentum Stock Watchlist - newser.com
Will Perspective Therapeutics Inc. stock beat value stocks2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Will Perspective Therapeutics Inc. (AAJ0) stock keep high P E multiplesTrade Signal Summary & High Accuracy Trade Alerts - newser.com
Will Perspective Therapeutics Inc. stock announce special dividendWeekly Trade Review & Capital Efficiency Focused Strategies - newser.com
How Perspective Therapeutics Inc. stock reacts to inflationary pressures2025 Growth vs Value & Long-Term Growth Plans - newser.com
Why Perspective Therapeutics Inc. (AAJ0) stock is listed among top recommendations2025 Market Trends & Long Hold Capital Preservation Plans - newser.com
Can Perspective Therapeutics Inc. stock hit record highs againTrade Entry Report & Fast Entry High Yield Stock Tips - newser.com
Can Perspective Therapeutics Inc. recover in the next quarterWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com
Is Perspective Therapeutics Inc. (AAJ0) stock a defensive play amid uncertaintyEarnings Miss & Long-Term Growth Plans - newser.com
Key metrics from Perspective Therapeutics Inc.’s quarterly dataTrade Risk Summary & Long-Term Safe Investment Plans - newser.com
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
Kapitalisierung:
|
Volumen (24h):